Literature DB >> 20702796

Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet.

Jill K Morris1, Gregory L Bomhoff, John A Stanford, Paige C Geiger.   

Abstract

Despite numerous clinical studies supporting a link between type 2 diabetes (T2D) and Parkinson's disease (PD), the clinical literature remains equivocal. We, therefore, sought to address the relationship between insulin resistance and nigrostriatal dopamine (DA) in a preclinical animal model. High-fat feeding in rodents is an established model of insulin resistance, characterized by increased adiposity, systemic oxidative stress, and hyperglycemia. We subjected rats to a normal chow or high-fat diet for 5 wk before infusing 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle. Our goal was to determine whether a high-fat diet and the resulting peripheral insulin resistance would exacerbate 6-OHDA-induced nigrostriatal DA depletion. Prior to 6-OHDA infusion, animals on the high-fat diet exhibited greater body weight, increased adiposity, and impaired glucose tolerance. Two weeks after 6-OHDA, locomotor activity was tested, and brain and muscle tissue was harvested. Locomotor activity did not differ between the groups nor did cholesterol levels or measures of muscle atrophy. High-fat-fed animals exhibited higher homeostatic model assessment of insulin resistance (HOMA-IR) values and attenuated insulin-stimulated glucose uptake in fast-twitch muscle, indicating decreased insulin sensitivity. Animals in the high-fat group also exhibited greater DA depletion in the substantia nigra and the striatum, which correlated with HOMA-IR and adiposity. Decreased phosphorylation of HSP27 and degradation of IκBα in the substantia nigra indicate increased tissue oxidative stress. These findings support the hypothesis that a diet high in fat and the resulting insulin resistance may lower the threshold for developing PD, at least following DA-specific toxin exposure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702796      PMCID: PMC2957375          DOI: 10.1152/ajpregu.00449.2010

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  59 in total

1.  Endocrine function and glucose metabolism in patients with Parkinson's disease and their alternation by L-Dopa.

Authors:  A E Boyd; H E Lebovitz; J M Feldman
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

2.  Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease.

Authors:  W Linert; E Herlinger; R F Jameson; E Kienzl; K Jellinger; M B Youdim
Journal:  Biochim Biophys Acta       Date:  1996-08-23

Review 3.  Compensations after lesions of central dopaminergic neurons: some clinical and basic implications.

Authors:  M J Zigmond; E D Abercrombie; T W Berger; A A Grace; E M Stricker
Journal:  Trends Neurosci       Date:  1990-07       Impact factor: 13.837

4.  Lipoic acid increases heat shock protein expression and inhibits stress kinase activation to improve insulin signaling in skeletal muscle from high-fat-fed rats.

Authors:  Anisha A Gupte; Gregory L Bomhoff; Jill K Morris; Brittany K Gorres; Paige C Geiger
Journal:  J Appl Physiol (1985)       Date:  2009-01-29

5.  Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury.

Authors:  C A Altar; M R Marien; J F Marshall
Journal:  J Neurochem       Date:  1987-02       Impact factor: 5.372

6.  Activation of glucose transport in muscle by prolonged exposure to insulin. Effects of glucose and insulin concentrations.

Authors:  D A Young; J J Uhl; G D Cartee; J O Holloszy
Journal:  J Biol Chem       Date:  1986-12-05       Impact factor: 5.157

7.  Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease.

Authors:  K Jellinger; L Linert; E Kienzl; E Herlinger; M B Youdim
Journal:  J Neural Transm Suppl       Date:  1995

8.  The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls.

Authors:  R Andrew; D G Watson; S A Best; J M Midgley; H Wenlong; R K Petty
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

9.  Glucose intolerance in Parkinson's disease.

Authors:  I J Lipman; M E Boykin; R E Flora
Journal:  J Chronic Dis       Date:  1974-12

Review 10.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

View more
  49 in total

1.  Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats.

Authors:  J K Morris; N B Seim; G L Bomhoff; P C Geiger; J A Stanford
Journal:  Neurosci Lett       Date:  2011-09-21       Impact factor: 3.046

Review 2.  Energy intake and exercise as determinants of brain health and vulnerability to injury and disease.

Authors:  Mark P Mattson
Journal:  Cell Metab       Date:  2012-11-15       Impact factor: 27.287

Review 3.  Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.

Authors:  Lijun Dai; Li Zou; Lanxia Meng; Guifen Qiang; Mingmin Yan; Zhentao Zhang
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

4.  Insulin resistance impairs nigrostriatal dopamine function.

Authors:  J K Morris; G L Bomhoff; B K Gorres; V A Davis; J Kim; P-P Lee; W M Brooks; G A Gerhardt; P C Geiger; J A Stanford
Journal:  Exp Neurol       Date:  2011-06-15       Impact factor: 5.330

5.  Effects of discontinuing a high-fat diet on mitochondrial proteins and 6-hydroxydopamine-induced dopamine depletion in rats.

Authors:  Delin Ma; Jeffrey M Shuler; Kayla D Raider; Robert S Rogers; Joshua L Wheatley; Paige C Geiger; John A Stanford
Journal:  Brain Res       Date:  2015-04-08       Impact factor: 3.252

6.  Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein.

Authors:  Kathleen J Griffioen; Sarah M Rothman; Bruce Ladenheim; Ruiqian Wan; Neil Vranis; Emmette Hutchison; Eitan Okun; Jean Lud Cadet; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2012-08-09       Impact factor: 4.673

7.  Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.

Authors:  Sarah M Rothman; Kathleen J Griffioen; Kenneth W Fishbein; Richard G Spencer; Sokratis Makrogiannis; Wei-Na Cong; Bronwen Martin; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2013-10-22       Impact factor: 4.673

Review 8.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

9.  A high fat diet alters metabolic and bioenergetic function in the brain: A magnetic resonance spectroscopy study.

Authors:  Kayla Raider; Delin Ma; Janna L Harris; Isabella Fuentes; Robert S Rogers; Joshua L Wheatley; Paige C Geiger; Hung-Wen Yeh; In-Young Choi; William M Brooks; John A Stanford
Journal:  Neurochem Int       Date:  2016-04-26       Impact factor: 3.921

Review 10.  Mitochondrial control of cell bioenergetics in Parkinson's disease.

Authors:  Raquel Requejo-Aguilar; Juan P Bolaños
Journal:  Free Radic Biol Med       Date:  2016-04-16       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.